Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Food Allergy Genetics and Epigenetics: A Review of Genome-Wide Association Studies.
Allergy·2024
Same author
The rs579459 ABO gene polymorphism and risk of incident cardiovascular events in obstructive sleep apnea: a pilot study.
Sleep & breathing = Schlaf & Atmung·2022
Is the aging process accelerated in chronic obstructive pulmonary disease?
Jee Lee1, Andrew Sandford, Paul Man
1Department of Medicine and the Providence Heart and Lung Institute at St. Paul’s Hospital, The University of British Columbia James Hogg Research Centre, Vancouver, British Columbia, Canada.
Current Opinion in Pulmonary Medicine
|March 3, 2011
Summary
Chronic obstructive pulmonary disease (COPD) may be linked to accelerated aging. Research indicates cellular senescence plays a role in COPD development and progression.
More Related Videos
Area of Science:
- Pulmonary Medicine
- Gerontology
- Cellular Biology
Background:
- Chronic obstructive pulmonary disease (COPD) is increasingly viewed as a condition associated with accelerated aging.
- The senescence hypothesis proposes that cellular aging contributes to COPD pathogenesis, supported by various experimental and clinical findings.
Purpose of the Study:
- To provide a comprehensive review of the senescence hypothesis in COPD.
- To summarize methodologies for assessing cellular aging in the context of COPD.
Main Methods:
- Review of in-vitro, in-vivo, and clinical studies.
- Analysis of senescence-associated protein expression in lung and circulation.
- Examination of telomere length and attrition in COPD patients.
- Assessment of cellular aging markers in lung fibroblasts and alveolar cells.
Main Results:
- COPD patients exhibit increased expression of senescence markers in lung tissue and circulation compared to controls.
- Accelerated aging models show emphysematous changes, mirroring COPD lung pathology.
- Studies suggest COPD patients may have accelerated telomere shortening, though results are heterogeneous.
- Senescence markers are elevated in fibroblasts and alveolar cells of COPD patients.
Conclusions:
- Growing evidence supports a role for accelerated aging in COPD progression.
- Cellular senescence represents a potential molecular pathway underlying COPD pathogenesis.